High blood levels of primary fatty acid amides (PFAMS), a class of fatty molecules involved in sleep and movement control, are associated with increased accumulation of beta-amyloid protein in the cerebrospinal fluid of patients with Alzheimer’s disease, a study finds. Researchers believe that this class of fatty molecules may represent a new blood biomarker that can help physicians diagnose Alzheimer’s earlier. Read the full article.
Sleep Molecules May Represent a New Blood Biomarker for Earlier Diagnosis, Study Suggests
aging Alzheimers alzheimers awareness Alzheimers Disease alzheimers prevention alzheimers risk alzheimers treatment blood brain brain health chakra cognition cognitive decline cognitive impairment cognitive problems Dementia diagnosis diet dietary habits early detection exercise food gender health health benefits inflammation lifestyle lifestyle medicine meditation Memory mental health mindfulness neurodegeneration neuroscience neuroscientists nutrition preventative care prevention research risk sleep treatment wellness women yoga